LSI Renews Pickleball Sponsorship, Shares Shift Downward
LSI Industries (NASDAQ: LYTS) shares lost ground Tuesday, as the Cincinnati-based firm, a leading U.S.-based manufacturer of commercial and industrial lighting and display solutions, announced the renewal of its partnership as an Official Lighting Sponsor of USA Pickleball. This extended collaboration highlights LSI’s commitment to advancing America's fastest-growing sport through innovative lighting technologies that enhance visibility, safety, and the overall playing experience.As the fastest-growing sport in the United States, pickleball is seeing unprecedented growth in both recreational and professional settings. LSI’s advanced lighting systems are uniquely designed to meet the specific needs of pickleball courts, delivering optimal illumination, reduced glare, and energy efficiency—whether for private clubs, recreation facilities, public parks, or tournament venues.“We are excited to extend our partnership with USA Pickleball,” said LSI Chief Marketing Officer Michael Prachar. “As the sport’s popularity continues to soar, our focus is on delivering the lighting innovations that players, facility owners, and tournament organizers can count on to elevate the game."LSI’s lighting solutions are engineered and manufactured in the United States, offering a dependable supply chain and meeting the highest quality standards. With decades of experience, LSI continues to deliver lighting systems that meet the demanding standards of sports and recreational environments.LYTS shares dipped 14 cents to $15.38.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


